Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581867 · ClinicalTrials.gov registry record · Phase 1
Memory and Insulin in Early Alzheimer's Disease
A Phase 1 study of Alzheimers Disease, sponsored by Jeff Burns, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT00581867: Completed Phase 1 study of Alzheimers Disease, sponsored by Jeff Burns, MD.
NCT00581867 is a Phase 1 study of Alzheimers Disease that has completed, run by Jeff Burns, MD. The registered enrollment target is 31 participants, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581867, a Phase 1 study of Alzheimers Disease, has completed, sponsored by Jeff Burns, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine which parts of the brain are involved in insulin-related memory improvement in early Alzheimer's disease and cognitively normal older adults.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Insulin Aspart
Study Locations (1)
Kansas
- University of Kansas Medical Center, Hoglund Brain Imaging Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-10 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581867
The ClinicalTrials.gov registry entry for NCT00581867 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (99% lower). The listed sponsor is Jeff Burns, MD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00581867 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT00581867 about?
NCT00581867 is a clinical study titled "Memory and Insulin in Early Alzheimer's Disease". To determine which parts of the brain are involved in insulin-related memory improvement in early Alzheimer's disease and cognitively normal older adults.
What is the current status of trial NCT00581867?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2007-10. Estimated completion is 2012-05.
What conditions does trial NCT00581867 study?
This clinical trial studies the following conditions: Alzheimers Disease.
What interventions are being tested in trial NCT00581867?
The interventions under investigation include: Placebo (DRUG), Insulin Aspart (DRUG).
Who is sponsoring clinical trial NCT00581867?
This trial is sponsored by Jeff Burns, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00581867 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
RECRUITING · Phase 1
-
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
RECRUITING · Phase 1
-
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
RECRUITING · Phase 1
-
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
RECRUITING · Phase 1
-
A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
RECRUITING · Phase 1
-
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.